loading

Iovance Biotherapeutics Inc Azioni (IOVA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
21.55%
59.95
49.32 58.55 31.11 0.715
Cost Of Revenue
13.92%
56.66
49.74 39.82 31.37 7.261
Gross Profit
888.49%
3.288
-0.417 18.73 -0.262 -6.546
Operating Expenses
3.10%
117.06
120.80 107.80 101.65 111.18
Benefits Costs and Expenses
1.37%
169.62
167.32 143.62 129.66 115.10
Costs And Expenses
1.87%
173.73
170.54 147.62 133.02 118.44
Operating Income/Loss
6.14%
-113.77
-121.22 -89.07 -101.91 -117.72
Income/Loss From Continuing Operations Before Tax
7.06%
-109.67
-118.00 -85.06 -98.56 -114.38
Income Tax Expense/Benefit, Deferred
208.16%
1.988
-1.838 -1.521 -1.458 -1.408
Income Tax Expense/Benefit
208.16%
1.988
-1.838 -1.52 -1.458 -1.408
Income/Loss From Continuing Operations After Tax
3.88%
-111.66
-116.16 -83.54 -97.10 -112.98
Net Income/Loss
3.88%
-111.66
-116.16 -83.54 -97.10 -112.98
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3.61%
0.3345
0.3229 0.3033 0.2848 266.22
Diluted Average Shares
3.61%
0.3345
0.3229 0.3033 0.2848 266.22
Basic Earnings Per Share
8.33%
-0.33
-0.36 -0.28 -0.34 -0.42
Diluted Earnings Per Share
8.33%
-0.33
-0.36 -0.28 -0.34 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.49
price up icon 0.70%
$83.96
price down icon 0.72%
$26.91
price up icon 2.49%
$105.94
price up icon 1.37%
$130.34
price up icon 1.60%
biotechnology ONC
$307.42
price down icon 0.70%
Capitalizzazione:     |  Volume (24 ore):